Iraq

Middle East

Contents

1. Regulatory Overview
2. Regulatory Pathways

Regulatory Overview

Iraq is regulated by the KIMADIA (State Company for Marketing Drugs and Medical Appliances). The country has 1 documented regulatory pathway for accessing unapproved or unlicensed medicines, covering named patient programs, compassionate use schemes, and special access arrangements.

Regulatory Authority

KIMADIA (State Company for Marketing Drugs and Medical Appliances)

Regulatory Pathways (1)

Iraqi MOH Exceptional Import Authorization 45 days

Iraq Ministry of Health exceptional import program allowing access to unregistered medicines for patients with serious conditions not treatable with locally available products.

Application Form: MOH Iraq Import Permission

Legal Basis: Iraqi Drug Regulation

Eligibility: Serious or life-threatening condition with no locally registered alternative

Reference: MOH Iraq Drug Import Policy

Iraq

ISO Code	`IQ`
Region	Middle East
Regulatory Authority	KIMADIA (State Company for Marketing Drugs and Medical Appliances)
Pathways	1 documented
Drugs Available	0 documented